chr12-110913195-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000432.4(MYL2):​c.353+51C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 1,613,286 control chromosomes in the GnomAD database, including 231 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 14 hom., cov: 33)
Exomes 𝑓: 0.014 ( 217 hom. )

Consequence

MYL2
NM_000432.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.211
Variant links:
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-110913195-G-T is Benign according to our data. Variant chr12-110913195-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 671321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-110913195-G-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0122 (1848/151498) while in subpopulation NFE AF = 0.0153 (1041/68008). AF 95% confidence interval is 0.0145. There are 14 homozygotes in GnomAd4. There are 1002 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYL2NM_000432.4 linkc.353+51C>A intron_variant Intron 5 of 6 ENST00000228841.15 NP_000423.2 P10916Q6IB42
MYL2NM_001406745.1 linkc.311+51C>A intron_variant Intron 4 of 5 NP_001393674.1
MYL2NM_001406916.1 linkc.296+51C>A intron_variant Intron 5 of 6 NP_001393845.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYL2ENST00000228841.15 linkc.353+51C>A intron_variant Intron 5 of 6 1 NM_000432.4 ENSP00000228841.8 P10916

Frequencies

GnomAD3 genomes
AF:
0.0122
AC:
1847
AN:
151378
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00209
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0457
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0153
Gnomad OTH
AF:
0.00957
GnomAD2 exomes
AF:
0.0136
AC:
3387
AN:
248922
AF XY:
0.0138
show subpopulations
Gnomad AFR exome
AF:
0.00171
Gnomad AMR exome
AF:
0.00770
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.000114
Gnomad FIN exome
AF:
0.0486
Gnomad NFE exome
AF:
0.0154
Gnomad OTH exome
AF:
0.0160
GnomAD4 exome
AF:
0.0143
AC:
20939
AN:
1461788
Hom.:
217
Cov.:
38
AF XY:
0.0141
AC XY:
10278
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00179
AC:
60
AN:
33480
American (AMR)
AF:
0.00803
AC:
359
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00210
AC:
55
AN:
26134
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00630
AC:
543
AN:
86250
European-Finnish (FIN)
AF:
0.0429
AC:
2291
AN:
53420
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5768
European-Non Finnish (NFE)
AF:
0.0152
AC:
16923
AN:
1111928
Other (OTH)
AF:
0.0111
AC:
673
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1342
2683
4025
5366
6708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0122
AC:
1848
AN:
151498
Hom.:
14
Cov.:
33
AF XY:
0.0135
AC XY:
1002
AN XY:
74082
show subpopulations
African (AFR)
AF:
0.00208
AC:
85
AN:
40806
American (AMR)
AF:
0.0114
AC:
175
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3464
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00621
AC:
30
AN:
4828
European-Finnish (FIN)
AF:
0.0457
AC:
484
AN:
10596
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0153
AC:
1041
AN:
68008
Other (OTH)
AF:
0.00947
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
3556

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.48
DANN
Benign
0.65
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2233260; hg19: chr12-111350999; API